← Back to Search

Behavioral Intervention

Usual Care + Health Promotion Intervention for Glaucoma (GOAL Trial)

N/A
Waitlist Available
Led By Laura Dreer, Ph.D.
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
English-speaking
cognitively oriented as defined by the Six-Item Screener (SIS) score of > 4 of 6
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3, 7 months, and 1 year
Awards & highlights

GOAL Trial Summary

This trial found that African Americans are at a higher risk for blindness from glaucoma and that current medication adherence methods are not working well for this population. A new culturally relevant, health promotion-based intervention was developed and piloted with promising results.

GOAL Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

GOAL Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3, 7 months, and 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3, 7 months, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in medication rate adherence via an electronic dosing aid
Secondary outcome measures
Depressive symptomatology
Glaucoma symptoms
Health beliefs and illness perception
+2 more
Other outcome measures
Medical factors
Sociodemographic variables

GOAL Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Usual Care + Health Promotion InterventionExperimental Treatment1 Intervention
Usual glaucoma care along with telehealth-based brief culturally informed health promotion intervention
Group II: Usual Care OnlyActive Control1 Intervention
Usual glaucoma management only, no intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Usual Care + Health Promotion Intervention
2018
N/A
~450

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,565 Previous Clinical Trials
2,267,917 Total Patients Enrolled
6 Trials studying Glaucoma
2,148 Patients Enrolled for Glaucoma
Laura Dreer, Ph.D.Principal InvestigatorUniversity of Alabama at Birmingham
2 Previous Clinical Trials
292 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacant opportunities for participants in this research experiment?

"Affirmative. The information hosted on clinicaltrials.gov indicates that this medical study is presently in the process of enrolling participants, with a first post date of July 13th 2018 and an edit made as recently as April 29th 2022. This trial requires 240 individuals across one site to take part."

Answered by AI

How many participants will be recruited for this research endeavor?

"Affirmative, the records on clinicaltrials.gov indicate that this experiment is currently recruiting participants. This research project was first published in July 2018 and last updated at the end of April 2022 with a total requirement for 240 patients from 1 centre."

Answered by AI
~66 spots leftby Mar 2025